New faster-acting and more effective treatments for Hepatitis C are transforming treatment - offering a cure for, and even eradication of, the potentially fatal infection.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
